Table 1.

Demographic characteristics of patients in both groups

Group	Median age (years)	Gender (M/F)	Baseline CDVA (logMAR)	Intermediate uveitis	Posterior uveitis	Median duration of quiescence (months)a
1 (n = 20)	47.3 ± 4.23 (35–58)	9/11	0.48 ± 0.1; (0.24–1.0)	11	9	9.25 ± 3.22 (4–15)
2 (n = 23)	49.12 ± 5.32 (37–61)	10/13	0.54 ± 0.14 (0.3–1.0)	16	7	11.40 ± 4 (4–19)

^aMedian duration of quiescence prior to inclusion in trial and scheduling of cataract surgery